Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-14-027605)

Filing Details

Accession Number:: 0001127602-14-027605
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-11 16:38:33
Reporting Period:: 2014-08-12

Filing Date:: 2014-09-11
Accepted Time:: 2014-09-11 16:38:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579873	J. Sarah Schlesinger	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-12	1,300	$5.52	1,300	No	4	P	Indirect	Spouse
Common Stock	Acquisiton	2014-08-13	1,300	$5.71	2,600	No	4	P	Indirect	Spouse
Common Stock	Acquisiton	2014-09-09	1,300	$5.93	3,900	No	4	P	Indirect	Spouse
Common Stock	Acquisiton	2014-09-10	1,300	$5.75	5,200	No	4	P	Indirect	Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Spouse
No	4	P	Indirect	Spouse
No	4	P	Indirect	Spouse
No	4	P	Indirect	Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,500	Direct

Footnotes

Shares were purchased pursuant to a 10b5-1 plan.